vitamin k epoxide reductases
Summary: OXIDOREDUCTASES which mediate vitamin K metabolism by converting inactive vitamin K 2,3-epoxide to active vitamin K.
- Johnson J, Caudle K, Gong L, Whirl Carrillo M, Stein C, Scott S, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update. Clin Pharmacol Ther. 2017;102:397-404 pubmed publisher..In addition, this updated guideline incorporates recommendations for adult and pediatric patients that are specific to continental ancestry. ..
- Zhang Y, Wang L, Zhang J, Li Y, He Q, Li H, et al. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. Eur J Nutr. 2014;53:221-32 pubmed..fragilis enriched vitamin K2-dependent osteocalcin mechanism in which AdipoR2, LXR-? and PPAR-? signaling were involved. ..
- Duzhiy I, Romanyuk A, Lyndin M, Bratushka V, Dubnytskiy V, Shevchenko Y, et al. [HORMONAL-GENETIC SCREENING IN PATIENTS, SUFFERING GASTRODUODENAL ULCER HEMORRHAGE]. Klin Khir. 2015;:24-7 pubmed..Diagnosis of polymorphic gene VKORC1 and expression of the estrogen receptors may serve the base for pathogenetic therapy in patients with hemorrhage occurrence. ..
- Levi F, Karaboué A, Saffroy R, Desterke C, Boige V, Smith D, et al. Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). Br J Cancer. 2017;117:965-973 pubmed publisher..VKORC1, NAT2 and ABCB1 variants predicted for HAI efficacy. Pharmacogenetics could guide the personalisation of liver-targeted medico-surgical therapies. ..